Merck Life Science A/S — Credit Rating and Financial Key Figures

Merck Life Science A/S (CVR number: 20830131) is a company from GLADSAXE. The company reported a net sales of 1536.2 mDKK in 2024, demonstrating a growth of 9.3 % compared to the previous year. The operating profit percentage was at 5.4 % (EBIT: 83.5 mDKK), while net earnings were 66.7 mDKK. The profitability of the company measured by Return on Assets (ROA) was 28 %, which can be considered excellent and Return on Equity (ROE) was 29.2 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 72.6 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. Merck Life Science A/S's liquidity measured by quick ratio was 3.4 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.